<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Reif LK</submitter><funding>NCATS NIH HHS</funding><funding>Flora Family Foundation</funding><funding>FIC NIH HHS</funding><funding>NIAID NIH HHS</funding><funding>Fogarty International Center</funding><funding>Camela Basin Family Foundation</funding><funding>Division of Intramural Research, National Institute of Allergy and Infectious Diseases</funding><funding>MAC AIDS Foundation</funding><pagination>409-420</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8976702</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>34(4)</volume><pubmed_abstract>HIV viral load (VL) monitoring can reinforce antiretroviral therapy (ART) adherence. Standard VL testing requires high laboratory capacity and coordination between clinic and laboratory which can delay results. A randomized trial comparing point-of-care (POC) VL testing to standard VL testing among 150 adolescents and young adults, ages 10-24 years, living with HIV in Haiti determined if POC VL testing could return faster results and improve ART adherence and viral suppression. Participants received a POC VL test with same-day result (POC arm) or a standard VL test with result given 1 month later (SOC arm). POC arm participants were more likely to receive a test result within 6 weeks than SOC arm participants (94.7% vs. 80.1%; p1000 copies/ml and low self-reported ART adherence was stronger in the POC arm (OR: 6.57; 95%CI: 2.12-25.21) than the SOC arm (OR: 2.62; 95%CI: 0.97-7.44) suggesting more accurate self-report in the POC arm. POC VL testing was effectively implemented in this low-resource setting with faster results and is a pragmatic intervention that may enable clinicians to identify those with high VL to provide enhanced counseling or regimen changes sooner.&lt;b>Trial registration:&lt;/b> ClinicalTrials.gov identifier: NCT03288246.</pubmed_abstract><journal>AIDS care</journal><pubmed_title>Point-of-care viral load testing among adolescents and young adults living with HIV in Haiti: a randomized control trial.</pubmed_title><pmcid>PMC8976702</pmcid><funding_grant_id>D43 TW10062</funding_grant_id><funding_grant_id>UL1 TR002384</funding_grant_id><funding_grant_id>D43 TW011295</funding_grant_id><funding_grant_id>U01 AI069421</funding_grant_id><funding_grant_id>UM1 AI069421</funding_grant_id><funding_grant_id>K24 AI098627</funding_grant_id><pubmed_authors>Reif LK</pubmed_authors><pubmed_authors>Kuhn L</pubmed_authors><pubmed_authors>Belizaire ME</pubmed_authors><pubmed_authors>Arpadi SM</pubmed_authors><pubmed_authors>Seo G</pubmed_authors><pubmed_authors>Rouzier V</pubmed_authors><pubmed_authors>Elul B</pubmed_authors><pubmed_authors>McNairy ML</pubmed_authors><pubmed_authors>Severe P</pubmed_authors><pubmed_authors>Pape JW</pubmed_authors><pubmed_authors>Fitzgerald DW</pubmed_authors><pubmed_authors>Joseph B</pubmed_authors><pubmed_authors>Apollon S</pubmed_authors><pubmed_authors>Abrams EJ</pubmed_authors><pubmed_authors>Bajo Joseph JM</pubmed_authors></additional><is_claimable>false</is_claimable><name>Point-of-care viral load testing among adolescents and young adults living with HIV in Haiti: a randomized control trial.</name><description>HIV viral load (VL) monitoring can reinforce antiretroviral therapy (ART) adherence. Standard VL testing requires high laboratory capacity and coordination between clinic and laboratory which can delay results. A randomized trial comparing point-of-care (POC) VL testing to standard VL testing among 150 adolescents and young adults, ages 10-24 years, living with HIV in Haiti determined if POC VL testing could return faster results and improve ART adherence and viral suppression. Participants received a POC VL test with same-day result (POC arm) or a standard VL test with result given 1 month later (SOC arm). POC arm participants were more likely to receive a test result within 6 weeks than SOC arm participants (94.7% vs. 80.1%; p1000 copies/ml and low self-reported ART adherence was stronger in the POC arm (OR: 6.57; 95%CI: 2.12-25.21) than the SOC arm (OR: 2.62; 95%CI: 0.97-7.44) suggesting more accurate self-report in the POC arm. POC VL testing was effectively implemented in this low-resource setting with faster results and is a pragmatic intervention that may enable clinicians to identify those with high VL to provide enhanced counseling or regimen changes sooner.&lt;b>Trial registration:&lt;/b> ClinicalTrials.gov identifier: NCT03288246.</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2026-05-09T13:44:57.706Z</modification><creation>2025-04-07T03:20:28.714Z</creation></dates><accession>S-EPMC8976702</accession><cross_references><pubmed>34612092</pubmed><doi>10.1080/09540121.2021.1981816</doi></cross_references></HashMap>